OMEICOS Therapeutics
0 followers
‌
OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.
Industries
Headquarters
Employees
Links
Org chart
Robert Fischer
Co-Founder, CEO & CSO
Robert Fischer
Collapse
Simon Russell
CBO, Consultancy
Karen Uhlmann
VP of Operations & IP, Co-Founder
Edita Bade
Head of Finance & Controlling
Anne Konkel
Klinischer Projektmanager
Janine Lossie
Clinical Project Manager
